Bringing natural killer cells to the clinic: ex vivo manipulation

被引：86

作者：

Childs, Richard W. ^{[1
]}

Berg, Maria ^{[1
]}

机构：

[1] NHLBI, Sect Transplantat Immunotherapy, Hematol Branch, NIH, Bethesda, MD 20892 USA

来源：

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2013年

关键词：

HEMATOPOIETIC STEM-CELLS; HUMAN NK CELLS; LARGE-SCALE; ACTIVATING RECEPTORS; GENETIC-MODIFICATION; INHIBITORY SIGNALS; ADOPTIVE TRANSFER; TUMOR-CELLS; IN-VITRO; EXPANSION;

D O I：

10.1182/asheducation-2013.1.234

中图分类号：

G40 [教育学];

学科分类号：

040101 ; 120403 ;

摘要：

Recently, there has been a substantial gain in our understanding of the role that natural killer (NK) cells play in mediating innate host immune responses against viruses and cancer. Although NK cells have long been known to be capable of killing cancer cells independently of antigen recognition, the full therapeutic potential of NK cell-based immunotherapy has yet to be realized. Here we review novel methods to activate and expand human NK cells ex vivo for adoptive transfer in humans, focusing on the important phenotypic and functional differences observed among freshly isolated, cytokine activated, and ex vivo-expanded NK populations.

引用

页码：234 / 246

页数：13

共 79 条

[1] Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components [J].

Alici, Evren ;

Sutlu, Tolga ;

Boejrkstrand, Bo ;

Gilljam, Mari ;

Stellan, Birgitta ;

Nahi, Hareth ;

Quezada, Hernan Concha ;

Gahrton, Goesta ;

Ljunggren, Hans-Gustaf ;

Dilber, M. Sirac .

BLOOD, 2008, 111 (06) :3155-3162

[2]

Alici Evren, 2009, V506, P127, DOI 10.1007/978-1-59745-409-4_10

[3] 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells [J].

Altvater, Bianca ;

Landmeier, Silke ;

Pscherer, Sibylle ;

Temme, Jaane ;

Schweer, Katharina ;

Kailayangiri, Sareetha ;

Campana, Dario ;

Juergens, Heribert ;

Pule, Martin ;

Rossig, Claudia .

CLINICAL CANCER RESEARCH, 2009, 15 (15) :4857-4866

[4] Allogeneic natural killer cells for refractory lymphoma [J].

Bachanova, Veronika ;

Burns, Linda J. ;

McKenna, David H. ;

Curtsinger, Julie ;

Panoskaltsis-Mortari, Angela ;

Lindgren, Bruce R. ;

Cooley, Sarah ;

Weisdorf, Daniel ;

Miller, Jeffrey S. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (11) :1739-1744

[5] Early Clinical Experience of aAPC Activated NK-DLI Following Allogeneic PBSCT in Pediatric Solid Tumor Patients. [J].

Baird, Kristin ;

Fry, Terry J. ;

Merchant, Melinda ;

Richards, Kelly ;

Delbrook, Cynthia ;

Wayne, Alan S. ;

Mackall, Crystal L. .

BLOOD, 2012, 120 (21)

[6] IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect [J].

Benson, Don M., Jr. ;

Bakan, Courtney E. ;

Zhang, Shuhong ;

Collins, Shauna M. ;

Liang, Jing ;

Srivastava, Shivani ;

Hofmeister, Craig C. ;

Efebera, Yvonne ;

Andre, Pascale ;

Romagne, Francois ;

Blery, Mathieu ;

Bonnafous, Cecile ;

Zhang, Jianying ;

Clever, David ;

Caligiuri, Michael A. ;

Farag, Sherif S. .

BLOOD, 2011, 118 (24) :6387-6391

[7] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody [J].

Benson, Don M., Jr. ;

Bakan, Courtney E. ;

Mishra, Anjali ;

Hofmeister, Craig C. ;

Efebera, Yvonne ;

Becknell, Brian ;

Baiocchi, Robert A. ;

Zhang, Jianying ;

Yu, Jianhua ;

Smith, Megan K. ;

Greenfield, Carli N. ;

Porcu, Pierluigi ;

Devine, Steven M. ;

Rotem-Yehudar, Rinat ;

Lozanski, Gerard ;

Byrd, John C. ;

Caligiuri, Michael A. .

BLOOD, 2010, 116 (13) :2286-2294

[8]

Berg M, 2009, BLOOD, V114, P463

[9] Ex-vivo expansion of NK cells: What is the priority - high yield or high purity? [J].

Berg, Maria ;

Childs, Richard .

CYTOTHERAPY, 2010, 12 (08) :969-970

[10] Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells [J].

Berg, Maria ;

Lundqvist, Andreas ;

McCoy, Philip, Jr. ;

Samsel, Leigh ;

Fan, Yong ;

Tawab, Abdul ;

Childs, Richard .

CYTOTHERAPY, 2009, 11 (03) :341-355

← 1 2 3 4 5 6 7 8 →